ATOMO DIAGNOSTICS LIMITED — Share Issue/Capital Change 2020

Oct 7, 2020

ASX Announcement

==> picture [182 x 52] intentionally omitted <==

8 October 2020

Notification of forthcoming release of escrowed securities

In accordance with ASX Listing Rule 3.10A, Atomo Diagnostics Limited (ASX:AT1) ( Atomo ) advises that the following Atomo securities will be released from voluntary escrow on Friday, 16 October 2020:

• 19,775,112 ordinary fully paid shares (quoted)

The shares detailed above have been subject to voluntary escrow restrictions since 16 April 2020, the date of commencement of quotation of Atomo’s ordinary fully paid shares.

For more information, please contact:

Jane Lowe John Kelly IR Department Managing Director, Atomo jane.lowe@irdepartment.com.au john.kelly@atomodiagnostics.com Phone: +61 411 117 774 Phone: +61 401 922 279

This announcement was authorised by John Kelly, Managing Director.

About Atomo

Atomo is an Australian medical device company supplying unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market. Atomo’s patented devices simplify testing procedures and enhance usability for professional users and untrained self-testers. Atomo has supply agreements in place for tests targeting infectious diseases including COVID-19, HIV and viral vs bacterial differentiation.

See more at www.atomodiagnostics.com.